CRVS
USDCorvus Pharmaceuticals Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$7.690
High
$7.780
Low
$7.010
Volume
0.51M
Company Fundamentals
Market Cap
567.6M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.85M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced that final data from its Phase 1/1b trial of
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct
The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners
The Institute for Follicular Lymphoma Innovation (IFLI), a global, non-profit, private foundation dedicated to accelerating the development of...
Related Stocks
BELFB
Bel Fuse Inc.
PKE
Park Aerospace Corp.
VAL
Valaris Limited Common Shares
MURA
Mural Oncology plc Ordinary Shares
PNFPP
Pinnacle Financial Partners Inc. Depositary shares of Pinnacle Financial Partners Inc. each representing a 1/40th Interest in a share of its 6.75% Fixed-Rate Non-Cumulative Perpetual Preferred Stock Series B
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.